News

Diabetes driving ‘mishaps’ halved by web-based intervention


 

AT EASD 2014

References

The National Institutes of Health funded the study, and Lifescan, Abbott, and Dex4 provided supplies, including glucose monitors and a fast-acting glucose. Dr. Cox and his coinvestigators had no conflicts of interest.

Pages

Recommended Reading

Liver grafts donated after circulatory death increase early risk of diabetes
MDedge Endocrinology
Prediabetes increases cancer risk by 15%
MDedge Endocrinology
Statins do not worsen diabetes microvascular complications, may be protective
MDedge Endocrinology
Insulin degludec noninferior to insulin detemir in pediatric diabetes
MDedge Endocrinology
After 3-year stumble, new weight-loss drug wins FDA approval
MDedge Endocrinology
FDA panel backs diabetes drug for weight loss indication
MDedge Endocrinology
GLP-1 and basal insulin offer improved glycemic control, weight loss in type 2 diabetes
MDedge Endocrinology
UTIs in type 2 diabetes can be costly
MDedge Endocrinology
Complications rise for young people who miss glycemic goals
MDedge Endocrinology
Triple-drug success foreshadows T2DM combo pill
MDedge Endocrinology